Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention

被引:46
作者
Narendra, C.
Srinath, M. S.
Babu, Ganesh
机构
[1] Krupanidhi Coll Pharm, Dept Pharmaceut, Bangalore 34, Karnataka, India
[2] Govt Coll Pharm, Dept Pharmaceut, Bangalore 27, Karnataka, India
关键词
metoprolol tartrate; factorial design; GFDDS; HPMC; bilayered tablet;
D O I
10.1208/pt070234
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of the present study was to develop an optimized gastric floating drug delivery system ( GFDDS) containing metoprolol tartrate ( MT) as a model drug by the optimization technique. A 23 factorial design was employed in formulating the GFDDS with total polymer content-to-drug ratio ( X-1), polymer-to-polymer ratio ( X-2), and different viscosity grades of hydroxypropyl methyl cellulose ( HPMC) ( X-3) as independent variables. Four dependent variables were considered: percentage of MT release at 8 hours, T-50%, diffusion coefficient, and floating time. The main effect and interaction terms were quantitatively evaluated using a mathematical model. The results indicate that X1 and X2 significantly affected the floating time and release properties, but the effect of different viscosity grades of HPMC ( K4M and K10M) was nonsignificant. Regression analysis and numerical optimization were performed to identify the best formulation. Fickian release transport was confirmed as the release mechanism from the optimized formulation. The predicted values agreed well with the experimental values, and the results demonstrate the feasibility of the model in the development of GFDDS.
引用
收藏
页数:7
相关论文
共 23 条
[1]   Optimisation of floating matrix tablets and evaluation of their gastric residence time [J].
Baumgartner, S ;
Kristl, J ;
Vrecer, F ;
Vodopivec, P ;
Zorko, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :125-135
[2]   OPTIMIZATION OF SOTALOL FLOATING AND BIOADHESIVE EXTENDED-RELEASE TABLET FORMULATIONS [J].
CHUEH, HR ;
ZIA, H ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (15) :1725-1747
[3]   Development of a novel controlled-release system for gastric retention [J].
Deshpande, AA ;
Shah, NH ;
Rhodes, CT ;
Malick, W .
PHARMACEUTICAL RESEARCH, 1997, 14 (06) :815-819
[4]   HIGUCHI SQUARE ROOT EQUATION APPLIED TO MATRICES WITH HIGH CONTENT OF SOLUBLE DRUG SUBSTANCE [J].
FESSI, H ;
MARTY, JP ;
PUISIEUX, F ;
CARSTENSEN, JT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1978, 1 (05) :265-274
[5]   MATHEMATICAL OPTIMIZATION TECHNIQUES IN DRUG PRODUCT DESIGN AND PROCESS ANALYSIS [J].
FONNER, DE ;
BUCK, JR ;
BANKER, GS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (11) :1587-+
[6]   INVITRO AND INVIVO EVALUATION OF AN ORAL SUSTAINED-RELEASE FLOATING DOSAGE FORM OF AMOXICILLIN TRIHYDRATE [J].
HILTON, AK ;
DEASY, PB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 86 (01) :79-88
[7]  
HOFFMAN BB, 2001, GOODMAN GILMANS PHAR, P255
[8]  
Hwang SJ, 1998, CRIT REV THER DRUG, V15, P243
[9]   CONCEPTION AND INVIVO INVESTIGATION OF PERORAL SUSTAINED-RELEASE FLOATING DOSAGE FORMS WITH ENHANCED GASTROINTESTINAL TRANSIT [J].
INGANI, HM ;
TIMMERMANS, J ;
MOES, AJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 35 (1-2) :157-164
[10]   DESIGN AND TESTING IN-VITRO OF A BIOADHESIVE AND FLOATING DRUG-DELIVERY SYSTEM FOR ORAL APPLICATION [J].
JIMENEZCASTELLANOS, MR ;
ZIA, H ;
RHODES, CT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 105 (01) :65-70